Literature DB >> 27501914

Depression risk in patients with late-onset rheumatoid arthritis in Germany.

Julia Drosselmeyer1, Louis Jacob2, Wolfgang Rathmann3, Michael A Rapp4, Karel Kostev5.   

Abstract

GOAL: The goal of this study was to determine the prevalence of depression and its risk factors in patients with late-onset rheumatoid arthritis (RA) treated in German primary care practices.
METHODS: Longitudinal data from general practices (n=1072) throughout Germany were analyzed. Individuals initially diagnosed with RA (2009-2013) were identified, and 7301 patients were included and matched (1:1) to 7301 controls. The primary outcome measure was the initial diagnosis of depression within 5 years after the index date in patients with and without RA. Cox proportional hazards models were used to adjust for confounders.
RESULTS: The mean age was 72.2 years (SD: 7.6 years). A total of 34.9 % of patients were men. Depression diagnoses were present in 22.0 % of the RA group and 14.3 % of the control group after a 5-year follow-up period (p < 0.001). In the multivariate regression model, RA was a strong risk factor for the development of depression (HR: 1.55, p < 0.001). There was significant interaction of RA and diagnosed inflammatory polyarthropathies (IP) (RA*IP interaction: p < 0.001). Furthermore, dementia, cancer, osteoporosis, hypertension, and diabetes were associated with a higher risk of developing depression (p values <0.001).
CONCLUSION: The risk of depression is significantly higher in patients with late-onset RA than in patients without RA for subjects treated in primary care practices in Germany. RA patients should be screened routinely for depression in order to ensure improved treatment and management.

Entities:  

Keywords:  Depression; Germany; Late-onset rheumatoid arthritis; Primary care; Risk factors

Mesh:

Year:  2016        PMID: 27501914     DOI: 10.1007/s11136-016-1387-2

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  26 in total

1.  Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis.

Authors:  Chris Dickens; Linda McGowan; David Clark-Carter; Francis Creed
Journal:  Psychosom Med       Date:  2002 Jan-Feb       Impact factor: 4.312

2.  The course of depression in recent onset rheumatoid arthritis: the predictive role of disability, illness perceptions, pain and coping.

Authors:  L Sharpe; T Sensky; S Allard
Journal:  J Psychosom Res       Date:  2001-12       Impact factor: 3.006

3.  Depression in patients with rheumatoid arthritis: description, causes and mechanisms.

Authors:  Mary Margaretten; Laura Julian; Patricia Katz; Edward Yelin
Journal:  Int J Clin Rheumtol       Date:  2011

Review 4.  An Integrative Review of Correlates and Predictors of Depression in Patients with Rheumatoid Arthritis.

Authors:  Monica Iaquinta; Susan McCrone
Journal:  Arch Psychiatr Nurs       Date:  2015-04-20       Impact factor: 2.218

5.  Prevalence of depression, anxiety and their risk factors in German women with breast cancer in general and gynecological practices.

Authors:  Louis Jacob; Laura Bleicher; Karel Kostev; Matthias Kalder
Journal:  J Cancer Res Clin Oncol       Date:  2015-09-16       Impact factor: 4.553

6.  Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis.

Authors:  Dennis C Ang; Hyon Choi; Kurt Kroenke; Frederick Wolfe
Journal:  J Rheumatol       Date:  2005-06       Impact factor: 4.666

7.  Depression in rheumatoid arthritis patients: demographic, clinical, and psychological predictors.

Authors:  Tanya Covic; Graham Tyson; David Spencer; Graydon Howe
Journal:  J Psychosom Res       Date:  2006-05       Impact factor: 3.006

8.  Validity and representativeness of the "Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies.

Authors:  H Becher; K Kostev; D Schröder-Bernhardi
Journal:  Int J Clin Pharmacol Ther       Date:  2009-10       Impact factor: 1.366

9.  Prevalence of depression in type 2 diabetes patients in German primary care practices.

Authors:  Louis Jacob; Karel Kostev
Journal:  J Diabetes Complications       Date:  2015-12-17       Impact factor: 2.852

10.  Increased risk of depression in patients with rheumatoid arthritis: a seven-year population-based cohort study.

Authors:  Miao-Chiu Lin; How-Ran Guo; Ming-Chi Lu; Hanoch Livneh; Ning-Sheng Lai; Tzung-Yi Tsai
Journal:  Clinics (Sao Paulo)       Date:  2015-02       Impact factor: 2.365

View more
  7 in total

1.  [Higher prevalence of depressive and anxiety symptoms in early arthritis patients in comparison to the normal population].

Authors:  D Freier; M Englbrecht; V Höhne-Zimmer; J Detert; G-R Burmester
Journal:  Z Rheumatol       Date:  2019-11       Impact factor: 1.372

2.  Prevalence of comorbidities and their associations with health-related quality of life and healthcare expenditures in patients with rheumatoid arthritis.

Authors:  JaeJin An; Eric Nyarko; Mohammad Adam Hamad
Journal:  Clin Rheumatol       Date:  2019-05-27       Impact factor: 2.980

3.  Persistence with biological drugs in patients treated in rheumatology practices in Germany.

Authors:  Louis Jacob; Thomas Chevalier; Karel Kostev
Journal:  Rheumatol Int       Date:  2018-11-24       Impact factor: 2.631

4.  Long-term use of benzodiazepines in older patients in Germany: a retrospective analysis.

Authors:  Louis Jacob; Michael A Rapp; Karel Kostev
Journal:  Ther Adv Psychopharmacol       Date:  2017-03-01

5.  Persistence and treatment-free interval in patients being prescribed biological drugs in rheumatology practices in Germany.

Authors:  Karel Kostev; Louis Jacob
Journal:  Eur J Clin Pharmacol       Date:  2019-01-21       Impact factor: 2.953

6.  Prevalence of depression, anxiety, adjustment disorders, and somatoform disorders in patients with age-related macular degeneration in Germany.

Authors:  Louis Jacob; Alexandra Spiess; Karel Kostev
Journal:  Ger Med Sci       Date:  2017-02-09

Review 7.  Management of inflammatory rheumatic conditions in the elderly.

Authors:  Clément Lahaye; Zuzana Tatar; Jean-Jacques Dubost; Anne Tournadre; Martin Soubrier
Journal:  Rheumatology (Oxford)       Date:  2019-05-01       Impact factor: 7.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.